Author Archive
Dynavax to resubmit hep B vaccine for approval after positive data
Dynavax Technologies Corp said its experimental hepatitis B vaccine was found to be safe and effective in a late-stage study, paving the way for the company to resubmit its marketing application. The earlier marketing application for the
The Best Diet Ever: Three Key Ingredients
As weight loss and maintenance is one of my specialties, I am often asked, "What is the best diet?" People are often disappointed by my response. I tell them, "The best diet meets three conditions:It's a
Oral contraceptive use early in pregnancy not tied to defects
By Andrew M. Seaman (Reuters Health) - Women who accidentally keep taking oral contraceptives after becoming pregnant shouldn't worry about birth defects, a new study suggests. An analysis of nearly 900,000 births found no connection between
Valeant to appoint interim CEO as Pearson remains hospitalized: source
By Sneha Banerjee and Carl O'Donnell (Reuters) - Valeant Pharmaceuticals International Inc will appoint an interim chief executive officer to replace Michael Pearson who is hospitalized, a source familiar with the matter told Reuters, news that
Conatus liver drug shows promise in mid-stage trial
(Reuters) - Conatus Pharmaceuticals Inc said its experimental drug reduced the presence of a protein fragment in patients with liver cirrhosis in a mid-stage trial. The drug, emricasan, showed a statistically significant reduction in the protein fragment,
Eli Lilly’s diabetes pill takes market share from J&J, Astra
Eli Lilly and Co's new Jardiance diabetes treatment has begun stealing market share from rival drugs in its class, the company said on Tuesday, bolstered by clinical trial data showing it slashed deaths by 32 percent in
FDA tightens clinical requirements for transvaginal devices
(Reuters) - The U.S. Food and Drug Administration said on Monday it had taken steps to strengthen the data requirements for surgical mesh devices when used to repair pelvic organ prolapse (POP) via the vagina. Over
Acadia buys private behavioral health services provider
(Reuters) - Acadia Healthcare Co Inc said it was buying Priory Group, a private behavioral care provider in the United Kingdom, for about 1.5 billion pounds ($2.2 billion) including debt of 925 million pounds. Priory, which offers
Italy confirms higher cancer, death rates from mob dumping
ROME (AP) — An Italian parliament-mandated health survey has confirmed higher-than-normal incidents of death and cancer among residents in and around Naples, thanks to decades of toxic waste dumping by the local Camorra mob.
Premature Birth Could Impact Fitness Later In Life
(Reuters Health) - Young adults who were born prematurely may have weaker muscles than their peers born at full term, a Finnish study suggests.These young adults born preterm also considered themselves less physically fit, even though